Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? by Konstantin Nikolaou, Andrea Forschner, Benjamin Weide, Claus Garbe, Christina Pfannenberg, Ahmed E Othman, Johannes Schwenck, Christian la Fougère, Ferdinand Seith, Brigitte Gückel, Martin Schwartz, Matthias Fenchel, Nina Schwenzer

Get full text

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy by Dirk Schadendorf, Celeste Lebbe, Teresa Amaral, Benjamin Weide, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Reinhard Dummer, Domenico Mallardo, Paolo A Ascierto, Piotr Rutkowski, Jason John Luke, Kilian Wistuba-Hamprecht, Mitchell P Levesque, Roberta Turiello, Elva Morretta, Maria Chiara Monti, Rosa Azzaro, Laurence Imhof, Marc Chevrier, Antje Sucker, Aldo Pinto, Silvana Morello

Get full text

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG by Dirk Schadendorf, Carola Berking, Lucie Heinzerling, Lisa Zimmer, Ralf Gutzmer, Alexander Kreuter, Andreas Stang, Elisabeth Livingstone, Benjamin Weide, Eleftheria Chorti, Selma Ugurel, Anja Gesierich, Jürgen C Becker, Peter Mohr, Max Schlaak, Patrick Terheyden, Janine Gronewold, Rudolf Herbst, Carmen Loquai, Sarah Knispel, Hildegard Lax, Carsten Weishaupt, Claudia Pföhler, Katharina C Kaehler, Jochen Utikal, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal

Get full text